Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

3.9K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pink1-mediated mitophagy in the endothelium releases proteins encoded by mitochondrial DNA and activates neutrophil responses during inflammation.

eLife·2026
Same author

Telomerase-mediated immortalization preserves the anti-inflammatory activity of dental pulp stem cell extracellular vesicles.

Frontiers in immunology·2026
Same author

Response to comment on "Perioperative copeptin elevations and prediction of myocardial injury and acute kidney injury after abdominal surgery: A preliminary prospective observational study".

Journal of the Formosan Medical Association = Taiwan yi zhi·2026
Same author

A role for ETV1 and endothelial cell-derived extracellular vesicle microRNAs in priming fibroblast response to vesicle-bound FGF2.

bioRxiv : the preprint server for biology·2026
Same author

Pentagalloyl glucose suppresses MSU crystal-induced gout inflammation and arachidonic acid production <i>in vitro</i> and <i>in vivo</i>.

Frontiers in pharmacology·2026
Same author

Multi-omics analysis of type II diabetic wound healing reveals CD44-mediated immune cell crosstalk dysfunction in mice and humans.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Apr 13, 2026

A Lab-On-A-Chip Platform for Stimulating Osteocyte Mechanotransduction and Analyzing Functional Outcomes of Bone Remodeling
08:28

A Lab-On-A-Chip Platform for Stimulating Osteocyte Mechanotransduction and Analyzing Functional Outcomes of Bone Remodeling

Published on: May 21, 2020

6.6K

Functionality of lyophilized osteoinductive EVs: a mechanistic study.

Chun-Chieh Huang1, Miya Kang1, Koushik Debnath1

  • 1Department of Oral Biology, University of Illinois Chicago, Chicago, IL, United States.

Frontiers in Bioengineering and Biotechnology
|November 6, 2024
PubMed
Summary

Lyophilization of mesenchymal stem cell-derived extracellular vesicles (MSC EVs) can maintain their function for regenerative medicine. Using dimethyl sulfoxide (DMSO) as a cryoprotectant preserves the bioactivity and cargo integrity of lyophilized MSC EVs.

Keywords:
BMP2 signalingbone regenerationengineered extracellular vesicleslyophilization of EVsmesenchymal stem cells

More Related Videos

Labeling of Extracellular Vesicles for Monitoring Migration and Uptake in Cartilage Explants
07:58

Labeling of Extracellular Vesicles for Monitoring Migration and Uptake in Cartilage Explants

Published on: October 4, 2021

2.5K
Platelet-Derived Extracellular Vesicle Functionalization of Ti Implants
04:16

Platelet-Derived Extracellular Vesicle Functionalization of Ti Implants

Published on: August 5, 2021

2.3K

Related Experiment Videos

Last Updated: Apr 13, 2026

A Lab-On-A-Chip Platform for Stimulating Osteocyte Mechanotransduction and Analyzing Functional Outcomes of Bone Remodeling
08:28

A Lab-On-A-Chip Platform for Stimulating Osteocyte Mechanotransduction and Analyzing Functional Outcomes of Bone Remodeling

Published on: May 21, 2020

6.6K
Labeling of Extracellular Vesicles for Monitoring Migration and Uptake in Cartilage Explants
07:58

Labeling of Extracellular Vesicles for Monitoring Migration and Uptake in Cartilage Explants

Published on: October 4, 2021

2.5K
Platelet-Derived Extracellular Vesicle Functionalization of Ti Implants
04:16

Platelet-Derived Extracellular Vesicle Functionalization of Ti Implants

Published on: August 5, 2021

2.3K

Area of Science:

  • Biotechnology
  • Regenerative Medicine
  • Cell Biology

Background:

  • Mesenchymal stem cell-derived extracellular vesicles (MSC EVs) are promising for regenerative medicine.
  • Lyophilization enhances the translational potential of EVs but requires functional stability assessment.
  • The mechanistic understanding of lyophilized EV functionality remains limited.

Purpose of the Study:

  • To investigate the functional and mechanistic bioactivity of fresh versus lyophilized MSC EVs.
  • To assess the impact of dimethyl sulfoxide (DMSO) as a cryoprotectant on EV stability and functionality.
  • To evaluate the efficacy of cryoprotected lyophilized EVs in vitro and in vivo.

Main Methods:

  • Functional engineering of osteoinductive MSC EVs.
  • Lyophilization of MSC EVs with DMSO as a cryoprotectant.
  • In vitro assays for endocytosis, cargo integrity, and pathway-specific activity.
  • In vivo bone regeneration studies.

Main Results:

  • DMSO cryoprotection preserved the functional stability of engineered MSC EVs post-lyophilization.
  • In vitro studies confirmed maintained endocytosis, cargo integrity, and pathway activity of lyophilized EVs.
  • In vivo bone regeneration results showed cryoprotected lyophilized EVs were comparable to fresh EVs.

Conclusions:

  • Dimethyl sulfoxide (DMSO) is an effective cryoprotectant for preserving MSC EV functionality after lyophilization.
  • Lyophilized MSC EVs, when cryoprotected, demonstrate retained bioactivity for regenerative applications.
  • These findings support the use of cryoprotectants for developing stable, lyophilized EV-based therapies.